Delivery Order SPE2DB22D2007-SPE2DB25FJ1GC
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of Levothyroxine 100 mcg vials. The contract has a ceiling value of $1,549.20 and runs through February 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Levothyroxine 100 MCG vials. The award, valued at $5,827.96, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,945.20 for the supply of 4,564,085,692 units of 100 mcg/5 ml vial of levothyroxine. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and also holds an Indefinite Delivery Contract (IDC) with DLA valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,507.56 firm fixed-price delivery order is for the supply of 4,568,153,003 units of 500 mcg Levothyroxine vials. The contract has an ultimate completion date of May 7, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $8,598.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Levothyroxine 125 mcg tablets, a medication used to treat thyroid disorders. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 4,560,797,370 vials of Levothyroxine 100 MCG to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,557.24 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a firm fixed price and an ultimate completion date of May 3, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDVC0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,797.52 firm fixed-price delivery order is for the supply of 4566985479 Levothyroxine 100 mcg vials. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Levothyroxine 100 MCG vials. The $8,998.25 firm fixed price delivery order was awarded on March 16, 2022, with a completion date of March 17, 2022. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,332.72 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 count bottles of the 137 mcg dosage of the drug levothyroxine. The contract has an ultimate completion date of December 12, 2024 and is a firm fixed price arrangement. Amerisourcebergen is a for-profit corporation registered in the System for Award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,556,604,296 vials of the medication Levothyroxine 100 MCG. The contract has a ceiling value of $3,583.33 and a period of performance through March 18, 2022. This is a delivery order contract with a firm fixed price pricing type. No set-aside designation is...